Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

People of African descent tend to have high levels of genetic diversity because of the population’s long history. Genetic studies of disease have focused on people of European descent in part because it has historically been easier to study groups that are genetically similar and in part because much of this research is done in Europe and North America, where this group is the easiest to access.

More sophisticated methods for analyzing genetic data that have been developed over the last few years make it possible to study more diverse populations. Geneticists have discovered that this diversity can be helpful in narrowing down the particular genetic mutation linked to a disease. However, such studies require very large groups of people. “That’s part of the reason we are aiming for 10,000 individuals just to get it started,” says Joanna Mountain, senior director of research at 23andMe. In addition, cheaper DNA chips mean that studies of this size are more affordable.

The 23andMe project was inspired in part by the company’s work with Henry Louis Gates, director of the W. E. B. Du Bois Institute for African and African American Research at Harvard University. Gates’s PBS documentaries use genetics to help people explore their ancestry. “He had been encouraging us to reach out to African Americans,” says Mountain. “But I pointed out that the genetic research results to date lack information for African Americans.”

Participants in the 23andMe study will be asked to fill out surveys on their general health history and common conditions, such as diabetes, allergies, asthma, and headaches. Asthma and some forms of migraines are more common in African Americans.

Rick Kittles, an associate professor at the University of Illinois who is advising 23andMe on the project, says that mistrust of research still exists among African Americans, given the disturbing history of the Tuskegee syphilis study, in which African American men thought they were being treated for the disease but were not. “As African Americans and Hispanics see themselves more and more in research, that mistrust starts to ease,” says Kittles, who is African American. “But it is utterly important to have underrepresented researchers like myself and others involved in these projects.”

Unlike more traditional research studies, participants will get the results of their tests and the meaning of their own genetic variations. “Our goal is to keep participants engaged and excited about research by telling them what we discovered,” says Mountain. The project is part of 23andMe’s growing emphasis on participatory research. It recently published the first results of a study of Parkinson’s disease that identified two new genetic risk factors.

“The 23andMe project is paradigm shifting in many ways,” says Kittles. “It allows people to be more proactive in understanding their ancestry and their own health.”

8 comments. Share your thoughts »

Credit: Technology Review

Tagged: Biomedicine, genome, genetics, disease, 23andMe

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me